ECSS
PFE icon

Eurizon Capital SGR SpA’s Pfizer PFE Stock Holding History

Eurizon Capital SGR SpA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9M Buy
909,039
+125,912
+16% +$3.29M 0.06% 235
2026
Q1 		$22M Sell
783,127
-1,199,996
-61% -$31.9M 0.07% 227
2025
Q4 		$49.4M Buy
+1,983,123
New +$50M 0.15% 117

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eurizon Capital SGR SpA's PFE Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $3.29M and bringing the position to 909,039 shares worth $21.9M. The position accounts for 0.06% of the portfolio, ranked #235.

Eurizon Capital SGR SpA first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $49.4M in Q4 2025. 2,817 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Eurizon Capital SGR SpA held 909,039 shares of Pfizer worth $21.9M as of Q2 2026.
  • Eurizon Capital SGR SpA bought 125,912 Pfizer shares in Q2 2026, an estimated $3.29M.
  • Pfizer made up 0.06% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #235 holding.
  • Eurizon Capital SGR SpA first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Pfizer position peaked at $49.4M in Q4 2025.
  • 2,817 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.